Germany
Japan
United Kingdom
China
TRIM21 human polyclonal antibody, Purified
| Applications | ELISA, ID |
| Reactivities | Human |
Antibodies
View as table DownloadJo-1 Antigen human polyclonal antibody, Purified
| Applications | ELISA, ID |
| Reactivities | Human |
RNP Antigen human polyclonal antibody, Purified
| Applications | ELISA, ID, WB |
| Reactivities | Human |
SSB human polyclonal antibody, Ig Fraction
| Applications | ELISA, ID |
| Reactivities | Human |
Topoisomerase I (TOP1) human polyclonal antibody, Purified
| Applications | ELISA, ID, WB |
| Reactivities | Human |
Sm (Smith Antigen) human polyclonal antibody, Purified
| Applications | ELISA, ID |
| Reactivities | Human |
USD 600.00
2 Weeks
BETVIA (allergen Bet v1) human monoclonal antibody, clone H.G27E9B1
| Applications | ELISA, IP |
| Reactivities | Pollen |
BETVIA human monoclonal antibody, clone H.G5F2A4.09
| Applications | ELISA, WB |
| Reactivities | Pollen |
USD 600.00
2 Weeks
Peptidase 1 / DERP1 human monoclonal antibody, clone H.AK6.A3.F4
| Applications | ELISA, WB |
USD 600.00
2 Weeks
Peptidase 1 / DERP1 human monoclonal antibody, clone H.AA.IV7A3
| Applications | ELISA, WB |
Peptidase 1 / DERP1 human monoclonal antibody, clone H.AK5.C
| Applications | ELISA, WB |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Biotin |
USD 990.00
5 Days
Chimaeric Human IgE anti Nitrophenyl-hapten (NP) human monoclonal antibody, clone JW8/1, Supernatant
| Applications | ELISA |
USD 580.00
5 Days
Chimaeric Human IgG2 anti Nitrophenyl-hapten (NP) human monoclonal antibody, clone JW183, Purified
| Applications | ELISA |
| Reactivities | Human |
BETVIA human monoclonal antibody, clone H.G26F6B2.06
| Applications | ELISA |
| Reactivities | Pollen |
BETVIA human monoclonal antibody, clone H.G11A9F3.03
| Applications | ELISA |
| Reactivities | Pollen |
BETVIA human monoclonal antibody, clone H.G28C10.01
| Applications | ELISA |
| Reactivities | Pollen |
BETVIA human monoclonal antibody, clone H.G3A3C2.04
| Applications | ELISA |
| Reactivities | Pollen |
USD 795.00
5 Days
Chimaeric human IgM anti Nitrophenyl-hapten (NP) human monoclonal antibody, clone THM, Supernatant
| Applications | ELISA |
SARS-CoV-2 N protein monoclonal antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein RBD monoclonal antibody
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 monoclonal antibody (CB6 biosimilar)
| Applications | ELISA, FC |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
SARS-CoV monoclonal antibody (CR3022 biosimilar)
| Applications | ELISA, FC |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
| Applications | ELISA, WB |
| Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
| Applications | ELISA, WB |
| Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
| Applications | ELISA, WB |
| Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
| Applications | ELISA, WB |
| Conjugation | Unconjugated |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
| Applications | ELISA, IF, IHC, IP, WB |
| Conjugation | Unconjugated |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
| Applications | ELISA, IF, IHC, IP, WB |
| Conjugation | His Tag |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
| Applications | ELISA, IF, IHC, IP, WB |
| Conjugation | Unconjugated |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
| Applications | ELISA, IF, IHC, IP, WB |
| Conjugation | Unconjugated |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
| Applications | ELISA, IF, IHC, IP, WB |
| Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
USD 523.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | ELISA, FC, IHC |
| Reactivities | Chimpanzee, Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-alpha-gal epitope (Clone m86)
| Applications | ELISA, FC |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Active filters
Applications
- ELISA
Antibody Hosts
- Human
Filter by
Target Symbol
- S (15)
- N (6)
- V5 (5)
- HIS (4)
- TNF (3)
- CD80 (2)
- EGFR (2)
- FN1 (2)
- S PROTEIN (2)
- SARS-COV-2 N PROTEIN (2)
- ALPHA-GAL EPITOPE (1)
- BETVI (1)
- BRD4 (1)
- CBX1 (1)
- CBX2 (1)
- CBX5 (1)
- CD38 (1)
- CD4 (1)
- CD40 (1)
- CD52 (1)
- CD70 (1)
- EPHA2 (1)
- ERBB2 (1)
- F (1)
- FAS (1)
- FOXP1 (1)
- FOXP2 (1)
- FOXP4 (1)
- GM2 (1)
- IL6R (1)
- ITGA5 (1)
- KMT5C (1)
- L3MBTL1 (1)
- PHLPI (1)
- PRDM4 (1)
- PRDM9 (1)
- PRMT3 (1)
- PRMT5 (1)
- SARS-COV-2 SPIKE PROTEIN (1)
- SETD7 (1)
- SFMBT1 (1)
- SSB (1)
- TDRD3 (1)
- TOP1 (1)
- TRIM21 (1)
- TYRP1 (1)
- VEGFA (1)
- WDR5 (1)
Reactivities
Isotypes
Clonalities
Conjugates
Modifications
- This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (12)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)